"In our world of co-creation, hyper-connectivity and exponentially growing technology, our science industry is in much need of disruption. Our slow processes, our steep barriers to entry, and our poor external and internal communication is eroding trust and discouraging talent. We speak to the innovators, iconoclasts and entrepreneurs intent on creating change in science. We record podcasts, we write editorials, we run events. This is Science: Disrupt." Have a look at https://sciencedisrupt.com and share your thoughts with us using [email protected]

"In our world of co-creation, hyper-connectivity and exponentially growing technology, our science industry is in much need of disruption. Our slow processes, our steep barriers to entry, and our poor external and internal communication is eroding trust and discouraging talent. We speak to the innovators, iconoclasts and entrepreneurs intent on creating change in science. We record podcasts, we write editorials, we run events. This is Science: Disrupt." Have a look at https://sciencedisrupt.com and share your thoughts with us using [email protected]

In today's episode we interviewed Dr Oliver Baker, the Head of Gene Editing & Embryology Core (GEEC) at King’s College London . In this facility at King’s, he is using crisp technology for gene editing.

If you have any comments or questions email us on [email protected]

In today's episode we interviewed Dr Oliver Baker, the Head of Gene Editing & Embryology Core (GEEC) at King’s College London . In this facility at King’s, he is using crisp technology for gene editing.

If you have any comments or questions email us on [email protected]

Dr Jonathan Chubb - http://www.ucl.ac.uk/lmcb/users/jonathan-chubb

Dr Jonathan Chubb - http://www.ucl.ac.uk/lmcb/users/jonathan-chubb

Francesco Iorio is a senior bioinformatician working with Open Targets: a public-private initiative involving teams at the Wellcome Trust Sanger Institute, the EMBL – European Bioinformatics Institute, GlaxoSmithKline and Biogen, with the mission of exploiting Big Data for systematically identifying new therapeutic targets.

Previously he was an ESPOD fellow in joint post-doctoral program between the European Bioinformatics Institute and the Wellcome Trust Sanger Institute under the guidance of Julio Saez-Rodriguez and Mathew Garnett.

If you have any comments or questions email us on [email protected]

Francesco Iorio is a senior bioinformatician working with Open Targets: a public-private initiative involving teams at the Wellcome Trust Sanger Institute, the EMBL – European Bioinformatics Institute, GlaxoSmithKline and Biogen, with the mission of exploiting Big Data for systematically identifying new therapeutic targets.

Previously he was an ESPOD fellow in joint post-doctoral program between the European Bioinformatics Institute and the Wellcome Trust Sanger Institute under the guidance of Julio Saez-Rodriguez and Mathew Garnett.

If you have any comments or questions email us on [email protected]

Stem Cells @ Lunch is digested back!

In today's episode we interviewed Dr Dinis Calado, a group leader in the Francis Crick Institute. His research aims to elucidate mechanisms by which healthy cells of the haematopoietic system become cancerous, with major focus on B lymphocytes.

If you have any comments or questions email us on [email protected]

Stem Cells @ Lunch is digested back!

In today's episode we interviewed Dr Dinis Calado, a group leader in the Francis Crick Institute. His research aims to elucidate mechanisms by which healthy cells of the haematopoietic system become cancerous, with major focus on B lymphocytes.

If you have any comments or questions email us on [email protected]